iconoclast:

"Hepalink filed their IPO document with the HK stock exchange.  Much of what they write about RVX is well known to us.  Hepalink says they own 38.8% of RVX; I was under the impression that they were north of 40%."

I believe the IPO they are issuing relates to OncoQuest and not Resverlogix, an Antibody-based Immuno-oncology, ovarian cancer.

IMO .... Koo